Compare $BIOQ vs $QNCX | Chartloom

Compare

$BIOQ vs $QNCX

Bioqual Inc · Quince Therapeutics Inc

BIOQ

Bioqual Inc

QNCX

Quince Therapeutics Inc

Compare $BIOQ vs $QNCX

Comparing Bioqual Inc and Quince Therapeutics Inc

BIOQBioqual Inc

QNCXQuince Therapeutics Inc

BIOQBioqual Inc

Market cap

$29M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.4%

YTD performance

-14.3%

52W performance

-40.0%

FCF yield

20.2%

QNCXQuince Therapeutics Inc

Market cap

$31M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-94.7%

52W performance

-91.7%

FCF yield

-151.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIOQ

QNCX

Detailed metrics comparison

BIOQ

Bioqual Inc

QNCX

Quince Therapeutics Inc

Market Cap

BIOQ$29M

QNCX$31M

Enterprise Value

BIOQ$18M

QNCX$-85M

Price

BIOQ$33.00

QNCX$31.73

P/E Ratio

BIOQN/A

QNCXN/A

P/S Ratio

BIOQ0.69x

QNCX0.00x

EV/Sales

BIOQ0.43x

QNCX0.00x

EV/EBITDA

BIOQ7.55x

QNCX0.00x

P/B Ratio

BIOQ0.84x

QNCX0.27x

P/FCF Ratio

BIOQ4.95x

QNCXN/A

EV/FCF

BIOQ3.05x

QNCX1.81x

PEG Ratio

BIOQN/A

QNCXN/A

Forward P/E (NTM)

BIOQN/A

QNCXN/A

Forward P/S (NTM)

BIOQN/A

QNCXN/A

Revenue (TTM)

BIOQ$42M

QNCX$0

Revenue Growth (YoY)

BIOQ-19.4%

QNCXN/A

Forward Rev Growth

BIOQ0.0%

QNCX114.8%

Gross Margin (TTM)

BIOQ7.9%

QNCX0.0%

Operating Margin (TTM)

BIOQ0.0%

QNCX0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

QNCX0.0%

Net Margin (TTM)

BIOQ-2.9%

QNCX0.0%

FCF Margin (TTM)

BIOQ14.0%

QNCXN/A

Net Income (TTM)

BIOQ$-1M

QNCX$-92M

FCF (TTM)

BIOQ$6M

QNCX$-47M

EPS (TTM)

BIOQ-$1.38

QNCX-$15.08

ROE (TTM)

BIOQ-346.0%

QNCX-12702.0%

ROA (TTM)

BIOQ-193.0%

QNCX-10448.0%

ROIC (TTM)

BIOQ-346.0%

QNCX-11143.0%

Cash

BIOQ$11M

QNCX$116M

Debt

BIOQ$0

QNCX$0

Net Cash/Debt

BIOQ$11M

QNCX$116M

Current Ratio (TTM)

BIOQ4.01x

QNCX14.52x

Quick Ratio (TTM)

BIOQ3.91x

QNCX14.28x

Debt/Equity (TTM)

BIOQ0.00x

QNCX0.48x

Debt/Assets (TTM)

BIOQ0.0%

QNCX0.0%

Interest Coverage (TTM)

BIOQN/A

QNCXN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

QNCX0.00x

Beta

BIOQ-0.48

QNCX1.80

52W Performance

BIOQ-40.0%

QNCX-91.7%

YTD Performance

BIOQ-14.3%

QNCX-94.7%

% from 52W High

BIOQ-69.6%

QNCX-96.5%

% from 52W Low

BIOQ1.5%

QNCX110.1%

Asset Turnover (TTM)

BIOQ0.66x

QNCX0.00x

FCF Yield (TTM)

BIOQ20.2%

QNCX-151.2%

Earnings Yield (TTM)

BIOQ-4.2%

QNCX-297.4%

Dividend Yield (TTM)

BIOQN/A

QNCXN/A

Rule of 40

BIOQ-5.4

QNCX0.0

EV/GP/RG

BIOQN/A

QNCXN/A

Ticker research

View BIOQ research View QNCX research

Metric	BIOQ Bioqual Inc	QNCX Quince Therapeutics Inc
Market & Valuation
Market Cap	$29M	$31M
Enterprise Value	$18M	$-85M
Price	$33.00	$31.73
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	0.00x
EV/Sales	0.43x	0.00x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	0.27x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	1.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$0
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	114.8%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	0.0%
Net Margin (TTM)	-2.9%	0.0%
FCF Margin (TTM)	14.0%	N/A
Net Income (TTM)	$-1M	$-92M
FCF (TTM)	$6M	$-47M
EPS (TTM)	-$1.38	-$15.08
ROE (TTM)	-346.0%	-12702.0%
ROA (TTM)	-193.0%	-10448.0%
ROIC (TTM)	-346.0%	-11143.0%
Financial Health
Cash	$11M	$116M
Debt	$0	$0
Net Cash/Debt	$11M	$116M
Current Ratio (TTM)	4.01x	14.52x
Quick Ratio (TTM)	3.91x	14.28x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	1.80
52W Performance	-40.0%	-91.7%
YTD Performance	-14.3%	-94.7%
% from 52W High	-69.6%	-96.5%
% from 52W Low	1.5%	110.1%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.00x
FCF Yield (TTM)	20.2%	-151.2%
Earnings Yield (TTM)	-4.2%	-297.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View QNCX research

Valuation

P/S Ratio

QNCX

0.00x

BIOQ

0.69x

EV/FCF

QNCX

1.81x

BIOQ

3.05x

Growth & revenue

Revenue Growth TTM

BIOQ

-19.4%

Forward Revenue Growth

QNCX

114.8%

BIOQ

0.0%

Profitability & performance

Gross Margin

BIOQ

7.9%

QNCX

0.0%

ROE

BIOQ

-346.0%

QNCX

-12702.0%

FCF Yield %

BIOQ

20.2%

QNCX

-151.2%

52-Week Performance

BIOQ

-40.0%

QNCX

-91.7%

Detailed metrics comparison

BIOQ

Bioqual Inc

QNCX

Quince Therapeutics Inc

Market Cap

BIOQ$29M

QNCX$31M

Enterprise Value

BIOQ$18M

QNCX$-85M

Price

BIOQ$33.00

QNCX$31.73

P/E Ratio

BIOQN/A

QNCXN/A

P/S Ratio

BIOQ0.69x

QNCX0.00x

EV/Sales

BIOQ0.43x

QNCX0.00x

EV/EBITDA

BIOQ7.55x

QNCX0.00x

P/B Ratio

BIOQ0.84x

QNCX0.27x

P/FCF Ratio

BIOQ4.95x

QNCXN/A

EV/FCF

BIOQ3.05x

QNCX1.81x

PEG Ratio

BIOQN/A

QNCXN/A

Forward P/E (NTM)

BIOQN/A

QNCXN/A

Forward P/S (NTM)

BIOQN/A

QNCXN/A

Revenue (TTM)

BIOQ$42M

QNCX$0

Revenue Growth (YoY)

BIOQ-19.4%

QNCXN/A

Forward Rev Growth

BIOQ0.0%

QNCX114.8%

Gross Margin (TTM)

BIOQ7.9%

QNCX0.0%

Operating Margin (TTM)

BIOQ0.0%

QNCX0.0%

EBITDA Margin (TTM)

BIOQ-0.1%

QNCX0.0%

Net Margin (TTM)

BIOQ-2.9%

QNCX0.0%

FCF Margin (TTM)

BIOQ14.0%

QNCXN/A

Net Income (TTM)

BIOQ$-1M

QNCX$-92M

FCF (TTM)

BIOQ$6M

QNCX$-47M

EPS (TTM)

BIOQ-$1.38

QNCX-$15.08

ROE (TTM)

BIOQ-346.0%

QNCX-12702.0%

ROA (TTM)

BIOQ-193.0%

QNCX-10448.0%

ROIC (TTM)

BIOQ-346.0%

QNCX-11143.0%

Cash

BIOQ$11M

QNCX$116M

Debt

BIOQ$0

QNCX$0

Net Cash/Debt

BIOQ$11M

QNCX$116M

Current Ratio (TTM)

BIOQ4.01x

QNCX14.52x

Quick Ratio (TTM)

BIOQ3.91x

QNCX14.28x

Debt/Equity (TTM)

BIOQ0.00x

QNCX0.48x

Debt/Assets (TTM)

BIOQ0.0%

QNCX0.0%

Interest Coverage (TTM)

BIOQN/A

QNCXN/A

Net Debt/EBITDA (TTM)

BIOQ0.00x

QNCX0.00x

Beta

BIOQ-0.48

QNCX1.80

52W Performance

BIOQ-40.0%

QNCX-91.7%

YTD Performance

BIOQ-14.3%

QNCX-94.7%

% from 52W High

BIOQ-69.6%

QNCX-96.5%

% from 52W Low

BIOQ1.5%

QNCX110.1%

Asset Turnover (TTM)

BIOQ0.66x

QNCX0.00x

FCF Yield (TTM)

BIOQ20.2%

QNCX-151.2%

Earnings Yield (TTM)

BIOQ-4.2%

QNCX-297.4%

Dividend Yield (TTM)

BIOQN/A

QNCXN/A

Rule of 40

BIOQ-5.4

QNCX0.0

EV/GP/RG

BIOQN/A

QNCXN/A

Ticker research

View BIOQ research View QNCX research

Metric	BIOQ Bioqual Inc	QNCX Quince Therapeutics Inc
Market & Valuation
Market Cap	$29M	$31M
Enterprise Value	$18M	$-85M
Price	$33.00	$31.73
P/E Ratio	N/A	N/A
P/S Ratio	0.69x	0.00x
EV/Sales	0.43x	0.00x
EV/EBITDA	7.55x	0.00x
P/B Ratio	0.84x	0.27x
P/FCF Ratio	4.95x	N/A
EV/FCF	3.05x	1.81x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$42M	$0
Revenue Growth (YoY)	-19.4%	N/A
Forward Rev Growth	0.0%	114.8%
Profitability
Gross Margin (TTM)	7.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.1%	0.0%
Net Margin (TTM)	-2.9%	0.0%
FCF Margin (TTM)	14.0%	N/A
Net Income (TTM)	$-1M	$-92M
FCF (TTM)	$6M	$-47M
EPS (TTM)	-$1.38	-$15.08
ROE (TTM)	-346.0%	-12702.0%
ROA (TTM)	-193.0%	-10448.0%
ROIC (TTM)	-346.0%	-11143.0%
Financial Health
Cash	$11M	$116M
Debt	$0	$0
Net Cash/Debt	$11M	$116M
Current Ratio (TTM)	4.01x	14.52x
Quick Ratio (TTM)	3.91x	14.28x
Debt/Equity (TTM)	0.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.48	1.80
52W Performance	-40.0%	-91.7%
YTD Performance	-14.3%	-94.7%
% from 52W High	-69.6%	-96.5%
% from 52W Low	1.5%	110.1%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.00x
FCF Yield (TTM)	20.2%	-151.2%
Earnings Yield (TTM)	-4.2%	-297.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-5.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIOQ research	View QNCX research